Tailoring Treatment in Localized Prostate Cancer: Comparative Effectiveness of HIFU, Cryoablation, and Robot-Assisted Radical Prostatectomy at 2-Year Follow-Up: Insights from Prospective Institutional Cohort

<b>Background:</b> In the evolving landscape of localized prostate cancer management, focal therapies such as high-intensity focused ultrasound (HIFU) and prostate gland cryoablation (PGC) have emerged as organ-sparing alternatives for patients with low- to intermediate-risk disease. While these strategies aim to preserve functional outcomes, comparative data against robot-assisted radical prostatectomy (RARP) remain scarce and heterogeneous. <b>Methods:</b> We conducted a prospective, single-center study evaluating oncologic and functional outcomes in patients with organ-confined prostate cancer (Grade Group ≤ 2) treated with HIFU (<i>n</i> = 49), PGC (<i>n</i> = 114), or RARP (<i>n</i> = 109). Outcomes were assessed using standardized definitions at a median follow-up of 22 months. Treatment failure was defined according to EAU guidelines, and Kaplan-Meier analysis was applied to time-to-event outcomes. <b>Results:</b> Focal therapy patients were older, more comorbid, and had lower baseline erectile function (each <i>p</i> < 0.001). RARP was associated with the longest operative time but yielded the lowest complication rate (2.75% vs. 20.4% for HIFU and 31.5% for PGC; <i>p</i> < 0.001). Catheter-related morbidity was disproportionately higher in the PGC group. RARP conferred a longer time to treatment failure (<i>p</i> < 0.001), although continence and potency recovery at follow-up were comparable across groups. Notably, erectile function returned earlier among HIFU patients. <b>Conclusions:</b> While focal therapies offer promising early functional results with minimal perioperative risk, they are associated with earlier treatment failure and higher catheter-related morbidity, particularly after cryoablation. These findings underscore the need for individualized treatment strategies guided by standardized, comparative outcome frameworks.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-08-25
DOI
https://doi.org/10.3390/cancers17172762
Citations
1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tailoring Treatment in Localized Prostate Cancer: Comparative Effectiveness of HIFU, Cryoablation, and Robot-Assisted Radical Prostatectomy at 2-Year Follow-Up: Insights from Prospective Institutional Cohort

Mariaconsiglia Ferriero, Gabriele Tuderti, Costantino Leonardo, Franco Lugnani et al.
1 citations
Cancers
Prostate Cancer Diagnosis and Treatment
1.52
article

Tailoring Treatment in Localized Prostate Cancer: Comparative Effectiveness of HIFU, Cryoablation, and Robot-Assisted Radical Prostatectomy at 2-Year Follow-Up: Insights from Prospective Institutional Cohort

Mariaconsiglia Ferriero, Gabriele Tuderti, Costantino Leonardo, Franco Lugnani, Aldo Brassetti, Rocco Simone Flammia, Andrea Iannuzzi, Riccardo Mastroianni, Umberto Anceschi, Alfredo Maria Bove, Giuseppe Simone, Flavia Proietti, Salvatore Guaglianone, Aldo Di Blasi, Leonardo Misuraca, Francesco Prata, Rocco Papalia, Eugenio Bologna, Leslie Claire Licari
article en
1 citations

Abstract

<b>Background:</b> In the evolving landscape of localized prostate cancer management, focal therapies such as high-intensity focused ultrasound (HIFU) and prostate gland cryoablation (PGC) have emerged as organ-sparing alternatives for patients with low- to intermediate-risk disease. While these strategies aim to preserve functional outcomes, comparative data against robot-assisted radical prostatectomy (RARP) remain scarce and heterogeneous. <b>Methods:</b> We conducted a prospective, single-center study evaluating oncologic and functional outcomes in patients with organ-confined prostate cancer (Grade Group ≤ 2) treated with HIFU (<i>n</i> = 49), PGC (<i>n</i> = 114), or RARP (<i>n</i> = 109). Outcomes were assessed using standardized definitions at a median follow-up of 22 months. Treatment failure was defined according to EAU guidelines, and Kaplan-Meier analysis was applied to time-to-event outcomes. <b>Results:</b> Focal therapy patients were older, more comorbid, and had lower baseline erectile function (each <i>p</i> < 0.001). RARP was associated with the longest operative time but yielded the lowest complication rate (2.75% vs. 20.4% for HIFU and 31.5% for PGC; <i>p</i> < 0.001). Catheter-related morbidity was disproportionately higher in the PGC group. RARP conferred a longer time to treatment failure (<i>p</i> < 0.001), although continence and potency recovery at follow-up were comparable across groups. Notably, erectile function returned earlier among HIFU patients. <b>Conclusions:</b> While focal therapies offer promising early functional results with minimal perioperative risk, they are associated with earlier treatment failure and higher catheter-related morbidity, particularly after cryoablation. These findings underscore the need for individualized treatment strategies guided by standardized, comparative outcome frameworks.

CancersVol. 17(17)
Università Campus Bio-Medico (IT), Ospedale di Rivoli (IT), National Cancer Institute (MY), Campus Bio Medico University Hospital (IT)
Openalex Percentile: Top 15%
Prostate Cancer Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.